Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C26H30N6O |
| Molecular Weight | 442.556 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(N)C1=CC=C(C=C1)C2=NC(NC3=CC=C(CCN4CCOCC4)C=C3)=NC=C2C#N
InChI
InChIKey=MROGTPNQSHMKIG-UHFFFAOYSA-N
InChI=1S/C26H30N6O/c1-26(2,28)22-7-5-20(6-8-22)24-21(17-27)18-29-25(31-24)30-23-9-3-19(4-10-23)11-12-32-13-15-33-16-14-32/h3-10,18H,11-16,28H2,1-2H3,(H,29,30,31)
| Molecular Formula | C26H30N6O |
| Molecular Weight | 442.556 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Scalable synthesis of the VEGF-R2 kinase inhibitor JNJ-17029259 using ultrasound-mediated addition of MeLi-CeCl3 to a nitrile. | 2008-02-01 |
|
| A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models. | 2004-09 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:11:58 GMT 2025
by
admin
on
Mon Mar 31 22:11:58 GMT 2025
|
| Record UNII |
95RGX89OQD
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
314267-57-7
Created by
admin on Mon Mar 31 22:11:58 GMT 2025 , Edited by admin on Mon Mar 31 22:11:58 GMT 2025
|
PRIMARY | |||
|
95RGX89OQD
Created by
admin on Mon Mar 31 22:11:58 GMT 2025 , Edited by admin on Mon Mar 31 22:11:58 GMT 2025
|
PRIMARY | |||
|
11464906
Created by
admin on Mon Mar 31 22:11:58 GMT 2025 , Edited by admin on Mon Mar 31 22:11:58 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |